Eldelumab (Anti-CXCL10 / IP-10)
Product Specifications
CAS Number
946414-98-8
Synonyms
BMS-936557; MDX-1100
Target
CXCR
Applications
GPCR & G Protein
Additionnal Information
Eldelumab (Anti-CXCL10 / IP-10) is a humanised monoclonal antibody (IgG1 type) targeting CXCL10. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740173-100 1x 100 µL
CD45 / LCA (136-4B5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882980-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2980R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY422870 100 µg
C9orf117 (CFAP157) (NM_001012502) Human Over-expression Lysate
Sign In for Pricing
View Details 